1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ng-nitroarginine methyl ester in 60 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ng-nitroarginine methyl ester) | Trials (ng-nitroarginine methyl ester) | Recent Studies (post-2010) (ng-nitroarginine methyl ester) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 12,640 | 117 | 2,342 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | ng-nitroarginine methyl ester (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 2.7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.1 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.1167 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.6 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 8 | |
| Collagenase 3 | Homo sapiens (human) | 2.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 37 (61.67) | 18.2507 |
| 2000's | 20 (33.33) | 29.6817 |
| 2010's | 3 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisayama, T; Kondoh, W; Miyano, H; Moritoki, H; Takeuchi, S | 1 |
| Crook, P; May, GR; Moore, PK; Page, CP | 1 |
| Barrachina, MD; Esplugues, JV; Martinez-Cuesta, MA; Piqué, JM; Whittle, BJ | 1 |
| Butler, KD; Crook, P; May, GR; Page, CP; Paul, W | 1 |
| Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
| Bailly, C; Imbert-Teboul, M; Néant, F | 1 |
| Durán, WN; Kim, D | 1 |
| Fujii, E; Irie, K; Muraki, T; Ohba, K; Uchida, Y | 1 |
| Alonso, A; Bosca, L; Crespo, MS; Garcia Rodriguez, MC; Steil, AA | 1 |
| Anderson, DC; Granger, DN; Kubes, P; Kurose, I; Miyasaka, M; Paulson, J; Wolf, R | 1 |
| Beierwaltes, WH; Carretero, OA; Potter, DL; Sigmon, DH | 1 |
| Albertini, M; Clement, MG | 1 |
| Berthiaume, N; Bkaily, G; Claing, A; D'Orléans-Juste, P; Rola-Pleszczynski, M; Sirois, P | 1 |
| Befus, D; Kanwar, S; Kubes, P; Wallace, JL | 1 |
| Caplan, M; Hsueh, W; MacKendrick, W | 1 |
| Caplan, MS; Hedlund, E; Hill, N; MacKendrick, W | 1 |
| Filep, JG; Földes-Filep, E | 1 |
| Arndt, H; Granger, DN; Kubes, P; Kurose, I; Russell, JB | 1 |
| Filep, JG; Földes-Filep, E; Sirois, P | 1 |
| Durán, WN; Kim, D; Minnicozzi, M; Oshiro, H; Quardt, SM; Ramírez, MM | 1 |
| Meijer, F; Ruijter, JM; Van Delft, JL; Van Haeringen, NJ | 1 |
| Capasso, F; Gaginella, TS; Izzo, AA; Mascolo, N | 2 |
| Matsuzaki, T; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
| Arima, S; Ito, S; Juncos, LA; Ren, Y | 1 |
| Autunes, E; De Nucci, G; Ferreira, HH; Flores, CA; Lima, CS; Medeiros, MV; Sannomiya, P | 1 |
| Ibbotson, G; Kubes, P; Niu, XF | 1 |
| Coston, AF; Klabunde, RE; Laniyonu, AA | 1 |
| Collins, LC; Roberts, AM | 1 |
| Friebe, WG; Scheuer, W; Thierse, HJ; Tibes, U; Voelter, W | 1 |
| Arese, M; Battaglia, E; Bussolino, F; Camussi, G; de Martino, A; Lupia, E; Montrucchio, G; Tizzani, A | 1 |
| Koyama, S; Matsuda, Y; Shibamoto, T; Wang, HG | 1 |
| Baydoun, AR; Cannon, TR; Mann, GE | 1 |
| Araújo, CV; Catelli, M; Cordeiro, RS; Estato, V; Lopes-Martins, RA; Tibiriçá, E | 1 |
| Fujii, E; Irie, K; Ishida, H; Muraki, T; Wada, K; Yoshioka, T | 1 |
| Alloatti, G; Camussi, G; De Martino, A; Montrucchio, G; Penna, C | 1 |
| Chłopicki, S; Olszanecki, R | 1 |
| László, F; Morschl, E; Nemcsik, J; Pávó, I; Pozsár, J; Whittle, BJ | 1 |
| Carratù, L; Faraone, S; Maniscalco, M; Sofia, M | 1 |
| Foreman, JC; Maggs, JR; Turner, PJ | 1 |
| Grassi, S; Pettorossi, VE | 1 |
| Alloatti, G; Camussi, G; Mariano, F; Penna, C | 1 |
| Akutsu, A; Hayakawa, S; Hirano, H; Imai, T; Ishii, K; Nakahara, T; Shigenobu, K; Tanaka, H; Tanaka, Y | 1 |
| Balogh, I; Kecskeméti, V | 1 |
| Hwang, EG; Jeon, SY; Jung, TG; Kim, EA; Kim, JP; Ma, YW | 1 |
| Bussolati, B; Camussi, G; Mariano, F; Migliori, M | 1 |
| Carratù, L; Ferrara, G; Maniscalco, M; Sofia, M | 1 |
| Bazan, NG; Bernatchez, PN; Gélinas, DS; Rollin, S; Sirois, MG | 1 |
| Bussolati, B; Camussi, G; Mariano, F; Migliori, M; Russo, S; Triolo, G | 1 |
| Handa, RK; Handa, SE; Strandhoy, JW | 1 |
| Alloatti, G; Altruda, F; Azzolino, O; Barberis, L; Bedendi, I; Bosco, O; Del Sorbo, L; Hirsch, E; Levi, R; Malan, D; Marcantoni, A; Montrucchio, G; Penna, C; Wymann, M | 1 |
| Rhee, CK | 1 |
| Bredt, DS; Hua, Z; Johns, RA; Tao, YX; Xu, Y; Zhang, B | 1 |
| Chong, T; Ramirez, R; Victorino, GP | 1 |
| Chang, KH; Jeon, EJ; Kim, DH; Lee, SK; Park, YS; Yeo, SW | 1 |
| Brkovic, A; Sirois, MG | 1 |
| Cui, S; Kurata, Y; Shibamoto, T; Takano, H; Zhao, Z | 1 |
| De Nucci, G; Donato, JL; Lilla, S; Lorenzetti, R; Maziero, AM | 1 |
| Asano, M; Cui, H; Du, W; Okamoto, Y; Shibamoto, T; Takuwa, N; Takuwa, Y; Yoshioka, K; Zhang, W | 1 |
| Kuda, Y; Kurata, Y; Shibamoto, T; Song, J; Tanida, M; Wang, M; Zhang, T | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide.
Topics: Animals; Cathartics; Enzyme Inhibitors; Gastric Mucosa; Gastrointestinal Motility; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Rats | 1998 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.
Topics: Adult; Airway Resistance; Bradykinin; Double-Blind Method; Female; Humans; Male; Nasal Obstruction; Nasal Provocation Tests; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor | 2000 |
Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Bronchial Hyperreactivity; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Receptor, Bradykinin B2 | 2000 |
57 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
Topics: Aging; Animals; Aorta, Thoracic; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Hemoglobins; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1992 |
The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit.
Topics: Adenosine Diphosphate; Animals; Arginine; Cerebrovascular Circulation; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Platelet Activation; Pulmonary Circulation; Rabbits | 1991 |
The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Azepines; Endotoxins; Female; Gastric Acid; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentagastrin; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles | 1992 |
The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit.
Topics: Animals; Anistreplase; Arginine; Blood Platelets; Diterpenes; Female; Fibrinogen; Fibrinolytic Agents; Ginkgolides; Hirudins; Injections, Intra-Arterial; Injections, Intravenous; Intracranial Embolism and Thrombosis; Lactones; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Polydeoxyribonucleotides; Rabbits; Recombinant Proteins; Thrombin | 1992 |
Effects of phospholipids on renal function.
Topics: Angiotensin II; Animals; Arginine; Diuresis; Dogs; Hemodynamics; Kidney; Lysophosphatidylcholines; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Platelet Activating Factor; Rats; Renal Artery; Renal Circulation; Structure-Activity Relationship; Vasodilation; Vasopressins | 1993 |
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Calcium; Chlorides; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Kidney Medulla; Kinetics; Loop of Henle; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Parathyroid Hormone; Platelet Activating Factor; Protein Kinase C; Time Factors; Vasopressins | 1994 |
Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arterioles; Capillary Permeability; Catechols; Cheek; Cricetinae; Genistein; Isoflavones; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitriles; Platelet Activating Factor; Protein-Tyrosine Kinases; Tyrphostins | 1995 |
Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Capillary Permeability; Cyclooxygenase Inhibitors; Dinoprostone; Eicosanoids; In Vitro Techniques; Indomethacin; Male; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Skin | 1995 |
Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Antibody Formation; Arginine; Arthus Reaction; Blotting, Northern; Cells, Cultured; Enzyme Induction; Extravasation of Diagnostic and Therapeutic Materials; Leucine; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peritoneal Cavity; Peritonitis; Phagocytes; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Specific Pathogen-Free Organisms | 1995 |
Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage.
Topics: Albumins; Animals; Arginine; Azepines; Blood Flow Velocity; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cyclic GMP; Intercellular Adhesion Molecule-1; Leukocytes; Male; NG-Nitroarginine Methyl Ester; P-Selectin; Phalloidine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Triazoles; Venules | 1993 |
Nitric oxide synthesis inhibition blocks reversal of two-kidney, one clip renovascular hypertension after unclipping.
Topics: Animals; Arginine; Bradykinin; Hypertension, Renovascular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Renal Circulation | 1995 |
In pigs, inhaled nitric oxide (NO) counterbalances PAF-induced pulmonary hypertension.
Topics: Administration, Inhalation; Animals; Arginine; Blood Pressure; Female; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pulmonary Artery; Swine; Vasoconstriction | 1994 |
Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.
Topics: Animals; Arginine; Azepines; Calcium Channels; Isradipine; Male; Mesenteric Arteries; Mesenteric Veins; NG-Nitroarginine Methyl Ester; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Wistar; Triazoles | 1994 |
Nitric oxide synthesis inhibition increases epithelial permeability via mast cells.
Topics: Animals; Arginine; Histamine Antagonists; Intestinal Mucosa; Intestine, Small; Leukocytes; Male; Mast Cells; NG-Nitroarginine Methyl Ester; Nitric Oxide; Permeability; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides | 1994 |
Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Enterocolitis, Pseudomembranous; Hematocrit; Intestines; Male; Mesenteric Artery, Superior; Necrosis; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Superoxides | 1993 |
The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
Topics: Animals; Arginine; Hypoxia; Intestines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1994 |
Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
Topics: Albumins; Animals; Arginine; Blood Pressure; Capillary Permeability; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar | 1993 |
Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Azepines; Benzopyrans; Blood Pressure; Cell Adhesion; Cell Communication; Cell Movement; Leukocytes; Leukotriene B4; Mesenteric Veins; Microscopy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinacrine; Rats; Rats, Inbred WKY; Regional Blood Flow; Triazoles; Venules | 1993 |
Nitric oxide modulates vascular permeability in the rat coronary circulation.
Topics: Animals; Arginine; Blood Proteins; Capillary Permeability; Coronary Circulation; Endothelins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Rats; Rats, Wistar | 1993 |
Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Male; Mesocricetus; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Signal Transduction | 1995 |
Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva.
Topics: Albumins; Animals; Arginine; Capillary Permeability; Conjunctiva; Conjunctivitis, Allergic; Enzyme Inhibitors; Female; Guanidines; Guinea Pigs; Ketorolac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Platelet Activating Factor; Regional Blood Flow; Tolmetin; Vasodilator Agents | 1995 |
Relationship between nitric oxide and platelet-activating factor in castor-oil induced mucosal injury in the rat duodenum.
Topics: Acid Phosphatase; Animals; Castor Oil; Cathartics; Diuretics, Osmotic; Duodenum; Isosorbide; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Rats; Rats, Wistar | 1996 |
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Topics: Animals; Benzoquinones; Biphenyl Compounds; Cell Count; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Eicosanoids; Female; Heptanoic Acids; Hypotension; Indomethacin; Isoquinolines; Lipoxygenase Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Antagonists; Pyridinium Compounds; Tetrahydroisoquinolines; Vascular Resistance | 1996 |
Platelet-activating factor dilates efferent arterioles through glomerulus-derived nitric oxide.
Topics: Animals; Arterioles; Enzyme Inhibitors; Humans; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Vasodilation | 1996 |
Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis.
Topics: Animals; Bradykinin; Carrageenan; Chemotaxis, Leukocyte; Enzyme Inhibitors; Leukocyte Count; Lipopolysaccharides; Male; N-Formylmethionine Leucyl-Phenylalanine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pleura; Rats; Rats, Wistar | 1996 |
A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions.
Topics: Animals; Cell Adhesion; Cell Communication; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Humans; Mast Cells; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidants; Oxidative Stress; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1996 |
Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor.
Topics: Animals; Blood Flow Velocity; Cell Adhesion; Cricetinae; Dexamethasone; Endotoxins; Lipopolysaccharides; Male; Mesocricetus; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor | 1997 |
Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
Topics: Analysis of Variance; Animals; Arterioles; Diterpenes; Enzyme Inhibitors; Ginkgolides; Lactones; Male; Muscle Tonus; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Trachea; Venules | 1997 |
Evidence for activation of cyclooxygenase-1/-2 by endogenous nitric oxide in adjuvant arthritic Lewis rats.
Topics: Animals; Arthritis, Experimental; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew | 1996 |
Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Topics: Animals; Azepines; Cell Movement; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Triazoles; Tumor Necrosis Factor-alpha | 1997 |
The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet activating factor-induced hypotension in anesthetized dogs.
Topics: Anesthetics; Animals; Blood Gas Analysis; Blood Pressure; Dogs; Enzyme Inhibitors; Female; Hematocrit; Hemodynamics; Hypertension, Pulmonary; Hypotension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Sympathetic Nervous System; Vasomotor System | 1998 |
Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation.
Topics: Animals; Annexin A1; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Cycloheximide; Dexamethasone; Enzyme Inhibitors; In Vitro Techniques; Lipopolysaccharides; Lipoxygenase; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Vasodilation | 1998 |
The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release.
Topics: Animals; Azepines; Blood Pressure; Cardiac Output; Carotid Arteries; Carotid Stenosis; Enzyme Inhibitors; Feedback; Female; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pressoreceptors; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles; Vascular Resistance; Vasoconstriction | 1997 |
Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice.
Topics: Animals; Azo Compounds; Capillary Permeability; Coloring Agents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Glycoconjugates; Guanidines; Hypoglycemic Agents; Indomethacin; Insulin; Male; Methylene Blue; Mice; Mice, Mutant Strains; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Skin; Streptozocin; Trypan Blue | 1999 |
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
Topics: Action Potentials; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Azepines; Cyclooxygenase Inhibitors; Depression, Chemical; Guinea Pigs; Heart; In Vitro Techniques; Indomethacin; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Propranolol; Triazoles; Tumor Necrosis Factor-alpha | 1999 |
Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
Topics: Animals; Azepines; Cell Movement; Endotoxemia; Indans; Lactic Acid; Lipopolysaccharides; Lung; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane A2; Triazoles | 1999 |
Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy.
Topics: Albumins; Animals; Capillary Permeability; Enzyme Inhibitors; Inflammation; Laparotomy; Leukotrienes; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes | 2000 |
Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei.
Topics: Action Potentials; Animals; Benzoates; Electric Stimulation; Imidazoles; Long-Term Potentiation; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Platelet Activating Factor; Rats; Rats, Wistar; Signal Transduction; Synaptic Transmission; Vestibular Nuclei | 2000 |
Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha.
Topics: Animals; Azepines; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Phospholipases A; Platelet Activating Factor; S-Nitroso-N-Acetylpenicillamine; Stereoisomerism; Triazoles; Tumor Necrosis Factor-alpha | 2000 |
Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats.
Topics: Animals; Apamin; Biological Factors; Blood Pressure; Charybdotoxin; Depression, Chemical; Endothelin-1; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 2000 |
The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
Topics: 4-Aminopyridine; Action Potentials; Animals; Azepines; Diterpenes; Electrophysiology; Fibrinolytic Agents; Ginkgolides; Glyburide; Guinea Pigs; Heart; In Vitro Techniques; Lactones; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Potassium Channel Blockers; Reperfusion Injury; Triazoles | 2000 |
Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.
Topics: Animals; Capillary Permeability; Coloring Agents; Enzyme Inhibitors; Evans Blue; Female; Microscopy, Fluorescence; Nasal Mucosa; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Trachea | 2001 |
Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes.
Topics: Cell Adhesion; Cell Communication; Cells, Cultured; Enzyme Inhibitors; Humans; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Leukocytes, Mononuclear; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 2002 |
Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects.
Topics: Administration, Intranasal; Adult; Albumins; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Nasal Lavage Fluid; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Premedication; Rhinitis; Statistics, Nonparametric | 2002 |
Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Topics: 1-Methyl-3-isobutylxanthine; Androstadienes; Animals; Calcimycin; Calcium; Cattle; Cells, Cultured; Chelating Agents; Chromones; Cyclic GMP; Diterpenes; Dose-Response Relationship, Drug; Egtazic Acid; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Ginkgolides; Indoles; Intercellular Signaling Peptides and Proteins; Ionophores; Lactones; Lymphokines; Maleimides; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serine; Signal Transduction; Time Factors; Type C Phospholipases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wortmannin | 2002 |
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.
Topics: Adult; Arginine; Cells, Cultured; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Humans; Lipopolysaccharides; Monocytes; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Platelet Activating Factor; Stereoisomerism; Tumor Necrosis Factor-alpha | 2003 |
Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
Topics: Acetylcholine; Animals; Arginine Vasopressin; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Injections; Injections, Intravenous; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Rats; Rats, Wistar; Renal Circulation; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2003 |
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility.
Topics: Animals; Azepines; Class Ib Phosphatidylinositol 3-Kinase; Female; In Vitro Techniques; Isoenzymes; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles | 2003 |
Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide?
Topics: Animals; Azepines; Cochlea; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Immunohistochemistry; Longitudinal Studies; Microscopy, Electron, Scanning; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Activating Factor; Random Allocation; Round Window, Ear; Triazoles | 2003 |
Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons.
Topics: Animals; Blotting, Western; Cell Count; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Diterpenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique; Ginkgolides; Guanylate Kinases; Intracellular Signaling Peptides and Proteins; Lactones; Membrane Proteins; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Tissue Proteins; Neurons; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Platelet Activating Factor; Precipitin Tests; Propidium; Receptors, N-Methyl-D-Aspartate | 2004 |
Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
Topics: Angiotensin II; Animals; Capillary Permeability; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2006 |
Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Ear, Middle; Enzyme Inhibitors; Etanercept; Immunoglobulin G; Immunohistochemistry; Indoles; Injections, Intralesional; Injections, Intraperitoneal; Lipopolysaccharides; Multivariate Analysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Otitis Media with Effusion; Photomicrography; Platelet Activating Factor; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Thiazoles; Tumor Necrosis Factor-alpha; Tympanic Membrane | 2006 |
Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
Topics: Animals; Antigens, CD; Blotting, Western; Cadherins; Capillary Permeability; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Humans; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Platelet Activating Factor; Vascular Endothelial Growth Factor A | 2007 |
L-NAME augments PAF-induced venoconstriction in isolated perfused livers of rat and guinea pig, but not mouse.
Topics: Animals; Guinea Pigs; Liver; Liver Circulation; Male; Mice; NG-Nitroarginine Methyl Ester; Perfusion; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction | 2007 |
Inhibition of human platelet aggregation by eosinophils.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Platelets; Chromatography, Gel; Collagen; Cytosol; Dextrans; Eosinophils; HL-60 Cells; Humans; Indomethacin; Male; Molecular Weight; NG-Nitroarginine Methyl Ester; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Wistar; Thrombin; Time Factors | 2013 |
Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Topics: Adherens Junctions; Anaphylaxis; Animals; Aorta; beta Catenin; Capillary Permeability; Disease Models, Animal; Endothelial Cells; Enzyme Activation; Gene Deletion; Lung; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Signal Transduction | 2013 |
The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Topics: Anaphylaxis; Animals; Arterial Pressure; Dose-Response Relationship, Drug; Histamine; Leukotriene C4; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Prostaglandin D2; Serotonin; Vascular Resistance; Vasoconstriction; Vasodilation | 2016 |